BigHat Biosciences

BigHat Biosciences is a biotech company based outside of San Francisco, focused on developing antibody therapies using machine learning and synthetic biology. They leverage their proprietary Milliner platform, which combines a high-speed wet lab for antibody characterization with state-of-the-art machine learning technologies to guide the design process. The company's mission is to create safer and more effective antibody therapies for patients suffering from challenging diseases, including oncology, inflammatory diseases, and immunology.

BigHat Biosciences has raised over $100 million in funding from top investors and boasts a high-performance culture that prioritizes excellence while also offering work/life balance and a family-friendly environment. Their interdisciplinary team includes scientists, engineers, and problem solvers, all committed to advancing drug design and development. BigHat has established partnerships with several leading biopharma companies, leveraging their expertise in therapeutic areas while benefiting from BigHat's advanced capabilities in antibody design and optimization.

BigHat Biosciences prioritizes work-life balance and has a family-friendly culture. They offer flexible work arrangements, including mentorship, unconstrained growth opportunities, clear guardrails to protect work-life balance, swift promotions with clear standards, autonomy and responsibility, fair compensation and recognition, and true work-life balance.

BigHat Biosciences emphasizes a high-performance culture of excellence but also prides itself on a strong work-life balance and family-friendly culture. They provide unique mentorship, unconstrained growth opportunities, and clear guardrails to protect work-life balance, resulting in swift promotions with clear standards, autonomy and responsibility, fair compensation and recognition, and true work-life balance. They also offer a state-of-the-art facility with natural light and beautiful views, easily reachable from the peninsula, San Francisco, and the East Bay.

BigHat Biosciences is a Series B biotech company committed to developing safer and more effective antibody therapies for patients using machine learning and synthetic biology. Their Milliner platform, a cutting-edge technology, integrates a high-speed wet lab with machine learning to guide the search for better antibodies, accelerating the process of discovering and engineering next-generation antibody treatments for a wide range of diseases including oncology, inflammatory diseases, and immunology.

BigHat Biosciences cultivates a high-performance culture that values excellence and growth while prioritizing work-life balance and a family-friendly environment. They foster a collaborative and team-oriented atmosphere, encouraging their employees to be subject matter experts, problem solvers, and driven individuals who enjoy getting things done.

BigHat Biosciences promotes a culture of diversity, equity, and inclusion by actively seeking out and employing a STEM-focused team of scientists, engineers, and problem solvers. Their commitment to DEI is reflected in their emphasis on a high-performance culture of excellence with clear guardrails to protect work/life balance, unconstrained growth opportunities, and fair compensation and recognition. The company prioritizes a family-friendly culture and a team-oriented collaborative environment, striving to create a welcoming and inclusive workplace for all.